Clinical trials
Phase 1 Arthritis, Psoriatic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2014 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 5 |
| Terminated | 4 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| UCB Biopharma SRL | 3 |
| Bio-Thera Solutions | 2 |
| Peking Union Medical College Hospital | 2 |
| UCB BIOSCIENCES, Inc. | 2 |
| Centocor, Inc. | 1 |
| Dr. Reddy's Laboratories Limited | 1 |
| Enlivex Therapeutics Ltd. | 1 |
| Fresenius Kabi SwissBioSim GmbH | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Psoriatic | 31 |
| Arthritis, Rheumatoid | 11 |
| Crohn Disease | 6 |
| Psoriasis | 6 |
| Spondylitis, Ankylosing | 6 |
| Autoimmune Diseases | 5 |
| Axial Spondyloarthritis | 5 |
| Lupus Erythematosus, Systemic | 4 |
| Arthritis, Juvenile | 3 |
| Colitis, Ulcerative | 3 |
Trials
Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.